J. Mizoe

发表

Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.

K. Takakura, H. Tsujii, H. Tsuji, 2007, International journal of radiation oncology, biology, physics.

Role of glucose metabolism and cellularity for tumor malignancy evaluation using FDG-PET/CT and MRI

Katsuyuki Tanimoto, Takayuki Obata, Hiroo Ikehira, 2009, Nuclear medicine communications.

Risk factors of late rectal bleeding after carbon ion therapy for prostate cancer.

H. Ishikawa, H. Tsujii, K. Akakura, 2006, International journal of radiation oncology, biology, physics.

Carbon ion radiotherapy for elderly patients 80 years and older with stage I non-small cell lung cancer.

H. Tsujii, R. Imai, S. Kandatsu, 2009, Lung cancer.

Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy.

Y. Okamoto, T. Onda, H. Tsujii, 2009, International journal of radiation oncology, biology, physics.

A horizontal CT system dedicated to heavy-ion beam treatment.

H Tsujii, S Minohara, M. Endo, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Carbon Ion Radiotherapy for Unresectable Sacral Chordomas

H. Tsujii, R. Imai, H. Tsuji, 2004, Clinical Cancer Research.

Acute toxicity of image-guided hypofractionated proton therapy for localized prostate cancer

Y. Shibamoto, Y. Umemoto, K. Nakajima, 2018, International Journal of Clinical Oncology.

Whole-pelvic radiotherapy with spot-scanning proton beams for uterine cervical cancer: a planning study

Y. Shibamoto, H. Iwata, H. Ogino, 2016, Journal of radiation research.

Clinical advantages of carbon-ion radiotherapy

H. Tsujii, H. Tsuji, R. Hara, 2008 .

Recovery from sublethal damage and potentially lethal damage

Y. Shibamoto, H. Iwata, C. Omachi, 2017, Strahlentherapie und Onkologie.

Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer.

H. Tsujii, Y. Osaka, S. Ebihara, 2004, International journal of radiation oncology, biology, physics.

The phase I/II clinical study of carbon ion therapy for cancer of the uterine cervix.

T. Nakano, H. Tsujii, S. Sato, 1999, The cancer journal from Scientific American.

Analysis of the dose-volume histogram in uterine cervical cancer by diagnostic CT.

J. Mizoe, 1990, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Dose escalation study of carbon ion radiotherapy for locally advanced carcinoma of the uterine cervix.

T. Nakano, T. Ohno, H. Tsujii, 2006, International journal of radiation oncology, biology, physics.

Curative treatment of Stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen.

H. Tsujii, T. Fujisawa, K. Yoshikawa, 2007, International journal of radiation oncology, biology, physics.

The role of radiotherapy in the management of maxillary sinus carcinoma

H. Shirato, T. Kamada, J. Mizoe, 1986, Cancer.

Feasibility of carbon ion radiotherapy for locally advanced sinonasal adenocarcinoma.

Y. Okamoto, H. Tsujii, K. Jingu, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Detection of tumor DNA in plasma using whole genome amplification.

T. Shibahara, A. Katakura, J. Mizoe, 2006, The Bulletin of Tokyo Dental College.

Image-Guided Proton Therapy for Elderly Patients with Hepatocellular Carcinoma: High Local Control and Quality of Life Preservation

Y. Shibamoto, K. Nakajima, H. Iwata, 2021, Cancers.

A Study on the Prognostic Evaluation of Carbon Ion Radiotherapy for Head and Neck Adenocarcinoma with C-11 Methionine PET

H. Tsujii, K. Kawaguchi, K. Yoshikawa, 2010, Molecular Imaging and Biology.

Title Detection of Microsatellite Alterations in Plasma DNA of Malignant Mucosal Melanoma Using Whole Genome Amplification

T. Shibahara, A. Katakura, J. Mizoe, 2019 .

Detection of microsatellite alterations in plasma DNA of malignant mucosal melanoma using whole genome amplification.

T. Shibahara, A. Katakura, J. Mizoe, 2008, The Bulletin of Tokyo Dental College.

LOH analysis of free DNA in the plasma of patients with mucosal malignant melanoma in the head and neck

H. Tsujii, J. Mizoe, R. Takagi, 2007, International Journal of Clinical Oncology.

A proton therapy system in Nagoya Proton Therapy Center

Y. Shibamoto, H. Iwata, C. Omachi, 2016, Australasian Physical & Engineering Sciences in Medicine.

Carbon ion radiation therapy for primary renal cell carcinoma: initial clinical experience.

H. Tsujii, H. Tsuji, K. Nemoto, 2008, International journal of radiation oncology, biology, physics.

D7-04: Carbon ion radiotherapy for peripheral stage I non small-cell lung cancer

H. Tsujii, R. Imai, S. Kandatsu, 2007 .

Examination of GyE system for HIMAC carbon therapy.

Tatsuaki Kanai, Hirotoshi Kato, Naruhiro Matsufuji, 2006, International journal of radiation oncology, biology, physics.

Physical and biological beam modeling for carbon beam scanning at Osaka Heavy Ion Therapy Center

K. Ogawa, T. Kanai, M. Takashina, 2021, Journal of applied clinical medical physics.

Proton Beam Therapy for Histologically or Clinically Diagnosed Stage I Non-small Cell Lung Cancer (NSCLC): The First Nationwide Retrospective Study in Japan.

H. Ishikawa, T. Akimoto, H. Sakurai, 2019, International journal of radiation oncology, biology, physics.

Outcomes of proton therapy for non-small cell lung cancer in patients with interstitial pneumonia

Y. Shibamoto, K. Nakajima, H. Iwata, 2021, Radiation Oncology.

DEVELOPMENT AND CLINICAL APPLICATION OF RESPIRATION GATED IRRADIATION SYSTEM (ReGIS) IN HEAVY ION RADIOTHERAPY

M. Endo, H. Tsujii, S. Minohara, 1999 .

RETROSPECTIVE ANALYSIS COMPARING COMBINED CHEMOTHERAPY AND RADIOTHERAPY WITH RADIOTHERAPY ALONE FOR NASOPHARYNGEAL CARCINOMA-UPDATED RESULTS OF HOKKAIDO UNIVERSITY TRIAL

H. Shirato, H. Tsujii, H. Tsuji, 1993 .

DNA repair capacity measured by high throughput alkaline comet assays in EBV-transformed cell lines and peripheral blood cells from cancer patients and healthy volunteers.

H. Yamazaki, T. Ohno, H. Tsujii, 2005, Mutation research.

Review of carbon ion radiotherapy for skull base tumors (especially chordomas).

J. Mizoe, 2016, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Skull base chordomas: efficacy of surgery followed by carbon ion radiotherapy

T. Kawase, Kazunari Yoshida, Satoshi Takahashi, 2009, Acta Neurochirurgica.

Dose prescription in carbon ion radiotherapy: a planning study to compare NIRS and LEM approaches with a clinically-oriented strategy

Roberto Orecchia, Silvia Molinelli, Mario Ciocca, 2012, Physics in medicine and biology.

Carbon ion radiotherapy for skull base chordoma.

T. Onda, H. Tsujii, J. Mizoe, 2009, Skull base : official journal of North American Skull Base Society ... [et al.].

Carbon ion radiation therapy improves the prognosis of unresectable adult bone and soft-tissue sarcoma of the head and neck.

H. Tsujii, K. Jingu, M. Tonogi, 2012, International journal of radiation oncology, biology, physics.

l-[METHYL-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy.

H. Tsujii, K. Yoshikawa, H. Ishikawa, 2008, International journal of radiation oncology, biology, physics.

Carbon-ion radiotherapy for locally advanced or unfavorably located choroidal melanoma: a Phase I/II dose-escalation study.

Y. Ohnishi, H. Ishikawa, H. Tsujii, 2007, International journal of radiation oncology, biology, physics.

Risk factors for neovascular glaucoma after carbon ion radiotherapy of choroidal melanoma using dose-volume histogram analysis.

Y. Ohnishi, S. Naganawa, H. Ishikawa, 2007, International journal of radiation oncology, biology, physics.

Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas.

Susumu Kandatsu, Hirotoshi Kato, Tadashi Kamada, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Title Mutation of the p 16 / CDKN 2 gene and loss of heterozygosity in malignant mucosal melanoma and adenoid cystic carcinoma of the head and neck

T. Onda, T. Shibahara, A. Katakura, 2017 .

Mutation of the p16/CDKN2 gene and loss of heterozygosity in malignant mucosal melanoma and adenoid cystic carcinoma of the head and neck.

T. Onda, T. Shibahara, A. Katakura, 2007, International journal of oncology.

Primary sebaceous carcinoma of the lacrimal gland treated by carbon ion radiotherapy

H. Tsujii, J. Mizoe, A. Hasegawa, 2003, International Journal of Clinical Oncology.

Changes in osteoclasts after irradiation with carbon ion particles

K. Tanimoto, J. Mizoe, M. Sawajiri, 2003, Radiation and environmental biophysics.

Changes in bone volume after irradiation with carbon ions

J. Mizoe, M. Sawajiri, 2003, Radiation and environmental biophysics.

A patient-specific aperture system with an energy absorber for spot scanning proton beams: Verification for clinical application.

Y. Shibamoto, C. Omachi, Y. Kibe, 2015, Medical physics.

Heavy Charged Particle Therapy( Stereotactic Radiosurgery Past, Present and Future)

H. Tsujii, J. Mizoe, A. Hasegawa, 2008 .

Changes in sexual function and serum testosterone levels in patients with prostate cancer after image-guided proton therapy

Y. Shibamoto, Y. Umemoto, K. Nakajima, 2021, Journal of radiation research.

Definitive carbon‐ion radiotherapy for locally advanced parotid gland carcinomas

Y. Okamoto, H. Tsujii, K. Jingu, 2017, Head & neck.

The Piotron: II. Methods and initial results of dynamic pion therapy in phase II studies.

E. Pedroni, H. Blattmann, J. Mizoe, 1985, International journal of radiation oncology, biology, physics.

Carbon ion radiotherapy for stage I non-small cell lung cancer.

Susumu Kandatsu, Naoyoshi Yamamoto, Hirotoshi Kato, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Mutation of the p 16 / CDKN 2 gene and loss of heterozygosity in malignant mucosal melanoma and adenoid cystic carcinoma of the head and neck

T. Onda, T. Shibahara, A. Katakura, 2018 .

Two cases of orbital adenocarcinoma treated with heavy charged carbon particle irradiation

S. Mine, A. Mizota, J. Mizoe, 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

SEQUENTIAL RADIOTHERAPY AND CHEMOTHERAPY USING CDDP AND 5-FU FOR ADVANCED HEAD AND NECK CANCER

J. Mizoe, T. Arimoto, T. Kitahara, 1991 .

Outcomes of visual acuity in carbon ion radiotherapy: analysis of dose-volume histograms and prognostic factors.

H. Tsujii, A. Mizota, J. Mizoe, 2006, International journal of radiation oncology, biology, physics.

Four-fraction carbon ion radiotherapy for hepatocellular carcinoma: results of a phase II clinical trial.

H. Tsujii, M. Ohto, T. Kamada, 2004, Journal of Clinical Oncology.

Carbon ion radiotherapy for locally advanced squamous cell carcinoma of the external auditory canal and middle ear

Y. Okamoto, H. Tsujii, K. Jingu, 2016, Head & neck.

Overview of clinical experiences on carbon ion radiotherapy at NIRS.

Riwa Kishimoto, Tatsuya Ohno, Susumu Kandatsu, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Rationale for carbon ion therapy in high-grade glioma based on a review and a meta-analysis of neutron beam trials.

D C Weber, J Balosso, D. Maucort-Boulch, 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Comparative study of dose distribution between carbon ion radiotherapy and photon radiotherapy for head and neck tumor

H. Tsujii, H. Mizuno, J. Mizoe, 2008, Radiation Medicine.

Initial clinical experience with scanned proton beams at the Italian National Center for Hadrontherapy (CNAO)

R. Orecchia, J. Tuan, B. Vischioni, 2013, Journal of radiation research.

Clinical Results of Carbon Ion Radiotherapy at NIRS.

Riwa Kishimoto, Tatsuya Ohno, Susumu Kandatsu, 2007, Journal of radiation research.

Spot Scanning and Passive Scattering Proton Therapy: Relative Biological Effectiveness and Oxygen Enhancement Ratio in Cultured Cells.

Y. Shibamoto, H. Iwata, C. Omachi, 2016, International journal of radiation oncology, biology, physics.

Evaluation of the safety and efficacy of carbon ion radiotherapy for locally advanced adenoid cystic carcinoma of the tongue base

Y. Okamoto, H. Tsujii, K. Jingu, 2016, Head & neck.

Results of carbon ion radiotherapy for head and neck cancer.

Tadashi Kamada, Hirohiko Tsujii, Keiichi Jingu, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Allelic loss on chromosomes 2q, 3p and 21q: possibly a poor prognostic factor in oral squamous cell carcinoma.

T. Shibahara, H. Tsujii, H. Noma, 2003, Oral oncology.

Allelic loss of chromosome 2 in human oral squamous cell carcinoma: correlation with lymph node metastasis.

T. Shibahara, H. Tsujii, K. Uzawa, 2003, Oral oncology.

Susceptible genes and molecular pathways related to heavy ion irradiation in oral squamous cell carcinoma cells.

T. Shibahara, H. Tsujii, T. Ishigami, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

ANALYSIS OF THE RESULTS OF POSTOPERATIVE RADIATION THERAPY AFTER SIMPLE TOTAL HYSTERECTOMY FOR CARCINOMA OF THE UTERINE CERVIX-ESPECIALLY IN STAGE Ib “occ”

R. Kishimoto, J. Mizoe, T. Arimoto, 1991 .

Genetic effects of X-ray and carbon ion irradiation in head and neck carcinoma cell lines.

T. Shibahara, T. Yakushiji, T. Nomura, 2007, The Bulletin of Tokyo Dental College.

Enhancement of SPHK1 in vitro by carbon ion irradiation in oral squamous cell carcinoma.

T. Shibahara, H. Tsujii, K. Uzawa, 2006, International journal of radiation oncology, biology, physics.

Malignant mucosal melanoma treated with carbon ion radiotherapy with concurrent chemotherapy: prognostic value of pretreatment apparent diffusion coefficient (ADC).

H. Tsujii, K. Jingu, H. Tsuji, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Carbon ion radiotherapy for non squamous cell carcinoma in head and neck region

H. Tsujii, J. Mizoe, A. Hasegawa, 2007 .

MR imaging of brain injury induced by carbon ion radiotherapy for head and neck tumors.

T. Obata, H. Tsujii, R. Kishimoto, 2005, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

Carbon ion radiotherapy: clinical experiences at National Institute of Radiological Science (NIRS).

Tohru Okada, H. Tsujii, R. Imai, 2010, Journal of radiation research.

High linear energy transfer carbon radiation effectively kills cultured glioma cells with either mutant or wild-type p53.

H. Tsujii, Y. Iwadate, A. Yamaura, 2001, International journal of radiation oncology, biology, physics.

Compensatory enlargement of the liver after treatment of hepatocellular carcinoma with carbon ion radiotherapy - relation to prognosis and liver function.

O. Yokosuka, H. Tsujii, S. Minohara, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis.

T. Obata, H. Tsujii, M. Tomizawa, 2004, International journal of radiation oncology, biology, physics.

Specification of Carbon Ion Dose at the National Institute of Radiological Sciences (NIRS).

Nobuyuki Kanematsu, Tatsuaki Kanai, Hirotoshi Kato, 2007, Journal of radiation research.

MRI of mucosal malignant melanoma of the head and neck.

Y. Itai, H. Yoshioka, H. Tsujii, 1998, Journal of computer assisted tomography.

Proton therapy for non-squamous cell carcinoma of the head and neck: planning comparison and toxicity

Y. Shibamoto, K. Nakajima, H. Iwata, 2019, Journal of radiation research.

[Treatment planning with head and neck immobilization shell. Use of thermo-plasticity polyester resin].

H Tsujii, G Irie, H. Shirato, 1984, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica.

Experience with carbon ion radiotherapy for WHO Grade 2 diffuse astrocytomas.

K. Takakura, H. Tsujii, Y. Iwadate, 2012, International journal of radiation oncology, biology, physics.

Influence of multiple genetic polymorphisms on genitourinary morbidity after carbon ion radiotherapy for prostate cancer.

H. Ishikawa, H. Tsujii, Shuhei Noda, 2008, International journal of radiation oncology, biology, physics.

Haplotype-based analysis of genes associated with risk of adverse skin reactions after radiotherapy in breast cancer patients.

Y. Shibamoto, H. Tsujii, J. Ohashi, 2007, International journal of radiation oncology, biology, physics.

Carbon-ion radiotherapy: clinical aspects and related dosimetry.

K. Noda, H. Tsujii, S. Minohara, 2009, Radiation protection dosimetry.

Effect of a Device-Free Compressed Shell Fixation Method on Hepatic Respiratory Movement: Analysis for Respiratory Amplitude of the Liver and Internal Motions of a Fiducial Marker.

Y. Shibamoto, K. Nakajima, H. Iwata, 2019, Practical radiation oncology.

Carbon ion radiotherapy using fiducial markers for prostate cancer in Osaka HIMAK: Treatment planning

T. Kanai, M. Takashina, M. Yagi, 2021, Journal of applied clinical medical physics.

Five-year results and complications with HDR afterloading in cervix cancer using a linear arrangement of source.

H. Shirato, T. Kamada, J. Mizoe, 1988, Sonderbande zur Strahlentherapie und Onkologie.

High-dose-rate intracavitary irradiation using linear source arrangement for stage II and III squamous cell carcinoma of the uterine cervix.

N. Sakuragi, K. Kagei, T. Nishioka, 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long‐term outcomes of proton therapy for prostate cancer in Japan: a multi‐institutional survey of the Japanese Radiation Oncology Study Group

H. Shirato, H. Ishikawa, T. Akimoto, 2018, Cancer Medicine.

Adverse effects of androgen deprivation therapy on persistent genitourinary complications after carbon ion radiotherapy for prostate cancer.

H. Ishikawa, T. Nakano, H. Tsujii, 2008, International journal of radiation oncology, biology, physics.

Is postoperative radiotherapy beneficial in the management of stage I-II squamous-cell carcinoma of the uterine cervix with negative metastatic nodes and positive parametrial involvement?: A retrospective review of 70 patients.

H. Shirato, H. Shirato, T. Kamada, 2010, Asia-Oceania journal of obstetrics and gynaecology.

Analysis of non-genetic risk factors for adverse skin reactions to radiotherapy among 284 Breast Cancer patients

H. Yamazaki, H. Tsujii, Shuhei Noda, 2006, Breast cancer.

Different effects of carbon ion and γ-irradiation on expression of receptor activator of NF-kB ligand in MC3T3-E1 osteoblast cells

K. Tanimoto, M. Okazaki, Y. Nomura, 2006, Bulletin of Experimental Biology and Medicine.

Carbon Ion Radiotherapy for Stage I Non-small Cell Lung Cancer Using a Regimen of Four Fractions during 1 Week

Susumu Kandatsu, Naoyoshi Yamamoto, Naoki Hirasawa, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Carbon ion radiation therapy for prostate cancer: results of a prospective phase II study.

Tatsuaki Kanai, Hitoshi Ishikawa, Tadashi Kamada, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Comparison of efficacy and toxicity of short-course carbon ion radiotherapy for hepatocellular carcinoma depending on their proximity to the porta hepatis.

O. Yokosuka, H. Tsujii, R. Kishimoto, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Preliminary calculation of RBE-weighted dose distribution for cerebral radionecrosis in carbon-ion treatment planning.

A. Nagano, S. Minohara, T. Kanai, 2011, Journal of radiation research.

Hypofractionated radiotherapy with carbon ion beams for prostate cancer.

Tatsuaki Kanai, Hitoshi Ishikawa, Tadashi Kamada, 2005, International journal of radiation oncology, biology, physics.

Feasibility of transrectal and transperineal fiducial marker placement for prostate cancer before proton therapy.

Y. Shibamoto, K. Nakajima, H. Iwata, 2020, Japanese journal of clinical oncology.

[Computed tomography of the kidney with diuretics--a method for avoiding artifacts due to nonionic contrast media].

S. Terae, T. Hiromura, J. Mizoe, 1989, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica.

Oxygen Enhancement Ratio of Proton Beams: The Precise Report of the Same Institution’s Experiments Using the Clinical Equipments

Y. Shibamoto, H. Iwata, C. Omachi, 2014 .

Transient increases in serum α fetoprotein and protein induced by vitamin K antagonist II levels following proton therapy does not necessarily indicate progression of hepatocellular carcinoma.

Y. Shibamoto, Y. Sekido, K. Nakajima, 2019, Oncology letters.

Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer

Y. Shibamoto, K. Nakajima, H. Iwata, 2018, Radiation oncology.

Phase II Study of Image-Guided Proton Therapy for Solitary Primary Hepatocellular Carcinoma with Indication for Standard Treatment

Y. Shibamoto, K. Nakajima, H. Iwata, 2018, International Journal of Radiation Oncology*Biology*Physics.

A proton therapy system in Nagoya Proton Therapy Center

Y. Shibamoto, H. Iwata, C. Omachi, 2016, Australasian Physical & Engineering Sciences in Medicine.

Experiences of carbon ion radiatiotherapy at NIRS

H. Tsujii, H. Tsuji, J. Mizoe, 2002 .

Transient increases in serum α fetoprotein and protein induced by vitamin K antagonist II levels following proton therapy does not necessarily indicate progression of hepatocellular carcinoma.

Y. Shibamoto, Y. Sekido, K. Nakajima, 2019, Oncology letters.